Pathologic Complete Response: all 138 studies
Page 2 of 2. Open to participants first (57), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune CytopeniaWithdrawnNCT03965624Phase 2
- Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid TumorsActive, not recruitingNCT03832569Early Phase 1
- Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine AvailabilityCompletedNCT03697928
- Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal AdenocarcinomaCompletedNCT03601689
- Triple-negative Breast Cancer: a New Perspective on BiomarkersCompletedNCT03539965
- Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerStatus unknownNCT03474341
- A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AMLStatus unknownNCT03417427Phase 2
- FLYSYN in MRD Positive AMLCompletedNCT02789254Phase 1/2
- Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast CancerCompletedNCT02613026Phase 3
- Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of AfatinibStatus unknownNCT02511847Phase 2
- Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)Active, not recruitingNCT02386670Not applicable
- Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal CancerCompletedNCT02353858Phase 2
- Evaluation of Immunochromatographic Tests for Campylobacter Detection in StoolsCompletedNCT02274922
- Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PETCompletedNCT02233374Not applicable
- Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical SettingCompletedNCT02232711
- Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast CancerStatus unknownNCT02059876Phase 2
- Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast CancerWithdrawnNCT01956513Not applicable
- Organ Preservation in Elderly Patients With Rectal CancerStatus unknownNCT01863862Not applicable
- Sulindac for Patients With AMLWithdrawnNCT01843179Phase 2
- IST Neoadjuvant Abraxane in Newly Diagnosed Breast CancerStatus unknownNCT01830244Phase 2
- Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in RemissionActive, not recruitingNCT01686334Phase 2
- Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal CancerCompletedNCT01648894Phase 3
- Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus NephritisCompletedNCT01580865Not applicable
- Metformin Plus Neoadjuvant Chemotherapy in Breast CancerStatus unknownNCT01566799Phase 2
- Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesCompletedNCT01471067Phase 1
- Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 YearsCompletedNCT01433926
- Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage SamplesCompletedNCT01430663
- Neoadjuvant 5-fluorouracil, Epirubicin and Cyclophosphamide (FEC) Followed by Weekly Paclitaxel and Trastuzumab in Her2 Positive Breast CancerCompletedNCT01340430Phase 2
- 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric CancerCompletedNCT01216644Phase 2/3
- Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast CancerCompletedNCT01203267Phase 2
- Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic SyndromeCompletedNCT01197040Phase 3
- VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)Status unknownNCT01134484Phase 3
- Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation MastitisCompletedNCT00620984
- Autologous Transplantation for Multiple MyelomaCompletedNCT00378222Phase 3
- Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior TherapyCompletedNCT00343720Phase 2
- Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)CompletedNCT00325676Phase 4
- RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With FamciclovirCompletedNCT00219310Phase 4
- Early Diagnosis of Candidiasis in Premature InfantsCompletedNCT00109525